Citation Information :
Rahman M, Noor-E-Alam SM, Rahim MA, Das DC, Ahmed F, Al Mamun A, Mahmud T, Mahmood T. Depression among Patients with Chronic Hepatitis B: A Cross-sectional Study in a Tertiary Hospital of Bangladesh. Euroasian J Hepatogastroenterol 2023; 13 (2):79-83.
Background: Patients with chronic hepatitis B suffer not only from physical illness. Rather, they often present with the mental health consequences of this chronic disease.
Objective: The major objective was to assess the level of depression among patients having chronic hepatitis B.
Method: The Department of Hepatology of Bangabandhu Sheikh Mujib Medical University directed this study which was a comparative cross-sectional study during time duration from September 2021 to September 2022. Incidence and grading of depression between patients with chronic hepatitis B and HBsAg negative healthy volunteers were assessed and compared through this study. The association of different variables with depression among chronic hepatitis B (CHB) patients was also measured.
Results: Out of 90 patients having chronic hepatitis B, 52 (57.8%) were found to have some degree of depression; whereas among 90 HBsAg-negative healthy controls, 32 (35.6%) were found to have various degrees of depression. The dissimilarity between the two groups was significantly determined (p-value < 0.05). The majority of the depressed population from both groups had mild degrees of depression, however, the variance was not top the notch (p-value > 0.05). But the prevalence of moderate depression and moderately severe depression was statistically significant among CHB patients compared to their counterpart controls. Depression among CHB patients was found to be female-predominant.
Conclusion: The study has shown a higher prevalence of depression among patients with chronic hepatitis B compared to HBsAg-negative healthy controls.
Dooley JS, Lok AS, Garcia-Tsao G, et al. Sherlock's diseases of the liver and biliary system. India: John Wiley & Sons; 2018. p. 70–75.
Mamun-Al-Mahtab, Rahman S, Khan M, et al. HEV infection as an aetiologic factor for acute hepatitis: Experience from a tertiary hospital in Bangladesh. J Health Popul Nutr 2009;27(1):14–19. DOI: 10.3329/jhpn.v27i1.3314.
Alavian SM. Hepatitis B virus infection in Iran; Changing the epidemiology. Iranian Journal of Clinical Infectious Disease 2010; 5(1):51–61.
Mahtab MA, Rahman S, Khan M, et al. Aetiology of chronic hepatitis in Bangladesh. Indian J Gastroenterol 2007;26(Suppl 2):142. Available from: https://doi.org/10.5005%2Fjp-journals-10018-1164.
Afroz S, Mahtab MA, Rahman S, et al. Hepatitis B virus is the leading cause of cirrhosis of liver in Bangladesh. Hepatol Int 2007;1(1):120. Available from: https://doi.org/10.5005%2Fjp-journals-10018-1164.
Terrault NA, Lok AS, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67(4):1560–1599. DOI: 10.1002/hep.29800.
Zhang M. Diagnosis and treatment of psychologic disorders in outpatients in general hospitals. Zhonghua yi xue za zhi 1999;79(5):325–326. PMID: 11715467.
Conrad S, Garrett LE, Cooksley WG, et al. Living with chronic hepatitis C means ‘you just haven't got a normal life any more’. Chronic Illn 2006;2(2):121–131. DOI: 10.1177/17423953060020020701.
Liu M, Li L, Zheng SJ, et al. Prevalence of major depression and its associations with demographic and clinical characteristics and quality of life in Chinese patients with HBV-related liver diseases. Arch Psychiatr Nurs 2017;31(3):287–290. DOI: 10.1016/j.apnu.2017. 02.004.
Keskin G, Gümüs AB, Orgun F. Quality of life, depression, and anxiety among hepatitis B patients. Gastroenterology Nurs 2013;36(5): 346–356. DOI: 10.1097/SGA.0b013e3182a788cc.
Alian S, Masoudzadeh A, Khoddad T, et al. Depression in hepatitis B and C, and its correlation with hepatitis drugs consumption (interfron/lamivodin/ribaverin). Iran J Psychiatry Behav Sci 2013;7(1):24–29. PMID: 24644496.
Vu TTM, Le TV, Dang AK, et al. ‘Socioeconomic vulnerability to depressive symptoms in patients with chronic hepatitis B’. Int J Environ Res Public Health 2019;16(2):255. DOI: 10.3390/ijerph16020255.